Abstract
Global cerebral ischemia and reperfusion (I/R) often result in high mortality. Free radicals play an important role in global cerebral I/R. Xanthine oxidoreductase (XOR) inhibitors, such as allopurinol, have been reported to protect tissues from damage caused by reactive oxygen species (ROS) by inhibiting its production through XOR inhibition. The recently introduced XOR inhibitor febuxostat, which is a more potent inhibitor than allopurinol, is expected to decrease free radical production more effectively. Here, we analyzed the effects of allopurinol and febuxostat in decreasing global severe cerebral I/R damage in mice. Mice were divided into three groups: a placebo group, an allopurinol group, and a febuxostat group. Pathological examinations, which were performed in each group in the CA1 and CA2 regions of the hippocampus 4 days after I/R surgery, revealed that there was a decrease in the number of neuronal cells in the 14-min occlusion model in both regions and that drugs that were administered to prevent this damage were not effective. The enzymatic activity was extremely low in the mouse brain, and XOR could not be detected in the nonischemic and ischemic mice brains with western blot analyses. Thus, one of the reasons f...Continue Reading
References
May 1, 1979·Stroke; a Journal of Cerebral Circulation·W A Pulsinelli, J B Brierley
Dec 1, 1991·The American Journal of Physiology·S LindsayJ S Beckman
Feb 1, 1991·The American Journal of Physiology·A L BetzD Martz
Apr 1, 1989·Stroke; a Journal of Cerebral Circulation·D MartzA L Betz
Jan 1, 1989·Advances in Experimental Medicine and Biology·Y HattoriA Ichikawa
Jan 17, 1985·The New England Journal of Medicine·J M McCord
Nov 1, 1986·Stroke; a Journal of Cerebral Circulation·T ItohM Nakamura
May 1, 1985·Stroke; a Journal of Cerebral Circulation·M KameyamaA Ogawa
Jan 1, 1984·Acta Neuropathologica·T KirinoK Sano
Jan 1, 1984·Acta Neuropathologica·M L SmithB K Siesjö
Nov 1, 1982·Neurology·W A PulsinelliF Plum
Sep 14, 1993·European Journal of Pharmacology·Y OsadaK Komoriya
Apr 1, 1993·Pediatric Research·C PalmerD F Heitjan
Apr 16, 1998·Neurologia Medico-chirurgica·R L Macdonald, M Stoodley
Oct 31, 2000·Journal of the Neurological Sciences·B C WhiteG S Krause
Aug 4, 2001·Neurosurgical Review·H AkdemirR K Koç
Nov 8, 2002·The Journal of Biological Chemistry·Ken OkamotoTakeshi Nishino
Jan 30, 2004·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Ichiro YonekuraTakaaki Kirino
Apr 15, 2004·Journal of Neurology·Tobias BackOlaf G Schüler
May 6, 2004·Journal of Neuroscience Methods·Julia KoflerRichard J Traystman
Aug 10, 2004·The Journal of Experimental Biology·David S WarnerInes Batinić-Haberle
Nov 1, 2005·Surgical Neurology·Nejat IşikAydin Sav
Dec 13, 2005·The New England Journal of Medicine·Michael A BeckerNancy Joseph-Ridge
Dec 8, 2006·Nature·Ed S LeinAllan R Jones
Jun 3, 2008·The FEBS Journal·Tomoko NishinoTakeshi Nishino
Jul 5, 2008·Nucleosides, Nucleotides & Nucleic Acids·Ken OkamotoTakeshi Nishino
Aug 7, 2010·Journal of Neuroscience Methods·Serge C ThalNikolaus Plesnila
Mar 18, 2011·Journal of Perinatal Medicine·Domokos Boda
Sep 29, 2011·Brain Research Bulletin·Li-Xian LiBruno P Meloni
Citations
Aug 1, 2015·PloS One·Masahiro YamaguchiHiroyuki Yokota
Oct 23, 2019·Signal Transduction and Targeted Therapy·Mrinal K GhoshMalini Basu
Dec 7, 2018·Neurotoxicology·Nicole R LaferriereLisa M Pierce
Oct 12, 2020·Signal Transduction and Targeted Therapy·Mrinal K GhoshMalini Basu